公开(公告)号：US20230309582A1

公开(公告)日：2023-10-05

申请号：US18042925

申请日：2021-08-25

Applicant: DAESANG CORPORATION

Inventor： Bo-Ra KIM ,  Ji-Eun HWANG ,  Jin-Young JEON

IPC: A23L2/52 ,  A23L29/269 ,  A23L29/238 ,  A23L2/46 ,  A23C9/152

CPC classification number: A23L2/52 ,  A23L29/27 ,  A23L29/238 ,  A23L2/46 ,  A23C9/152

Abstract: Provided are a beverage composition comprising: chlorophyll-deficient Chlorella; a specific gum as a stabilizer; and an aqueous liquid medium and a process for preparing the same, wherein the beverage composition exhibits excellent dispersion stability without precipitation, and prevent the browning phenomenon occurring in a sterilization process.

公开(公告)号：US20180303109A1

公开(公告)日：2018-10-25

申请号：US15771862

申请日：2016-10-28

Applicant: SAN-EI GEN F.F.I., INC.

Inventor： Norikazu FUJIMOTO ,  Taketoshi WATANABE ,  Hisakatsu IWABUCHI

IPC: A23C9/152 ,  A23G9/32 ,  A23L2/38 ,  A23L27/00

CPC classification number: A23C9/152 ,  A23G9/32 ,  A23G9/44 ,  A23G9/52 ,  A23L2/38 ,  A23L27/84 ,  A23V2002/00

Abstract: An object of the present invention is to provide a deterioration-odor masking agent and a deterioration-odor masking method capable of effectively masking deterioration odor of dairy products.The object is attained by a masking agent comprising one or more members selected from the group consisting of menthyl acetate, linalyl acetate, isoamyl isovalerate, isoamyl butyrate, nerol, acetaldehyde, methyl salicylate, 1,8-cineole, maltol isobutyrate, ethyl pyruvate, heliotropine, diethyl malonate, γ-butyrolactone, ethyl levulinate, benzyl alcohol, hexanal, γ-hexalactone, ethyl propionate, and amyl acetate.

公开(公告)号：US20180049460A1

公开(公告)日：2018-02-22

申请号：US15555867

申请日：2016-02-29

Applicant: INNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD ,  INNER MONGOLIA DAIRY TECHNOLOGY RESEARCH INSTITUTE CO., LTD

Inventor： Fang Fang ,  Ting Li ,  Zifu Zhao ,  Bingli Qi ,  Wenyou Situ ,  Wei Li ,  Biao Liu ,  Hongxia Zhao ,  Qingshan Chen

IPC: A23L33/13 ,  A23L33/00 ,  A23C9/152

CPC classification number: A23L33/13 ,  A23C9/152 ,  A23C9/16 ,  A23L33/40

Abstract: A nucleotide composition used as a food additive consists of 58-72% CMP, 6-14% AMP, 10-18% UMP and 8-14% GMP, or consists of 58-70% CMP, 7.5-12.5% AMP, 12-16.5% UMP, 10-13% GMP and 0-2.5% IMP. The composition is used to prepare foods, such as an infant food and a dairy product, and achieves the following effects: improving immunostimulation, promoting growth and development, facilitating repair after intestinal injury, promoting the growth of intestinal beneficial microorganisms, and/or any combination thereof.

公开(公告)号：US20170304309A1

公开(公告)日：2017-10-26

申请号：US15526207

申请日：2015-11-13

Applicant: UNIVERSITAT DE VALÈNCIA ,  INSTITUT QUÍMIC DE SARRIÀ CETS FUNDACIÓ PRIVADA ,  INSTITUT UNIV. DE CIÈNCIA I TECNOLOGIA, S.A.

Inventor： Ruben ARTERO ALLEPUZ ,  Josep CASTELLS BOLIART ,  José Ignacio BORRELL BILBAO ,  Beatriz LLAMUSI TROÍSI ,  Ariadna BARGIELA SCHÖNBRUNN ,  Piotr KONIECZNY ,  Marta PASCUAL GILABERT ,  Jordi TEIXIDÓ CLOSA ,  Roger ESTRADA TEJEDOR ,  Alejandro LÓPEZ GONZÁLEZ

IPC: A61K31/522 ,  A23L33/00 ,  A23L33/10 ,  A23L7/10 ,  A23C9/152

CPC classification number: A61K31/522 ,  A23C9/152 ,  A23L2/52 ,  A23L7/10 ,  A23L33/10 ,  A23L33/105 ,  A23L33/30 ,  A23V2002/00 ,  A61K2300/00 ,  A23V2200/316 ,  A23V2250/2108

Abstract: The present invention relates to caffeine for use in the treatment of myotonic dystrophy type 1 and type 2. The present invention also relates to compositions comprising caffeine for use in the treatment of myotonic dystrophy type 1 and type 2.

公开(公告)号：US20170274007A1

公开(公告)日：2017-09-28

申请号：US15513971

申请日：2015-09-21

Applicant: DOM TERRY INTERNATIONAL S.R.L.

Inventor： Domenico Terenzio ,  Luca Rastrelli ,  Chiara Parisella

IPC: A61K31/733 ,  A61K31/28 ,  A61K31/05 ,  A61K8/73 ,  A61K8/67 ,  A61K8/58 ,  A61K8/34 ,  A61K31/122 ,  A61K8/35 ,  A61K33/00 ,  A61K8/19 ,  A61K31/047 ,  A61K8/97 ,  A61K36/28 ,  A61K9/16 ,  A61K8/02 ,  A61Q19/10 ,  A61Q5/02 ,  A61K8/06 ,  A61K33/04 ,  A61K8/23 ,  C05D9/02 ,  C09B61/00 ,  A23L33/15 ,  A23L33/16 ,  A23L33/21 ,  A21D13/40 ,  A21D13/41 ,  A23C9/152 ,  A23C19/068 ,  A23G9/32 ,  A23G1/32 ,  A23L13/40 ,  C12G1/00 ,  A61K31/714

CPC classification number: A61K31/733 ,  A21D13/40 ,  A21D13/41 ,  A23C9/152 ,  A23C19/0684 ,  A23G1/32 ,  A23G9/32 ,  A23L13/42 ,  A23L33/15 ,  A23L33/16 ,  A23L33/21 ,  A23V2002/00 ,  A61K8/0225 ,  A61K8/06 ,  A61K8/19 ,  A61K8/23 ,  A61K8/345 ,  A61K8/347 ,  A61K8/35 ,  A61K8/355 ,  A61K8/58 ,  A61K8/673 ,  A61K8/73 ,  A61K8/97 ,  A61K9/1682 ,  A61K31/047 ,  A61K31/05 ,  A61K31/122 ,  A61K31/28 ,  A61K31/714 ,  A61K31/715 ,  A61K33/00 ,  A61K33/04 ,  A61K36/28 ,  A61K45/06 ,  A61Q5/02 ,  A61Q19/00 ,  A61Q19/10 ,  C05D9/02 ,  C07H23/00 ,  C09B1/00 ,  C09B61/00 ,  C12G1/00 ,  A61K2300/00

Abstract: The present invention relates to an inulin-based prebiotic complex enriched with vitamin B12 and selenium, which finds use in the field of food, nutraceutical, herbal, pharmaceutical preparations.

公开(公告)号：US09717773B2

公开(公告)日：2017-08-01

申请号：US15045709

申请日：2016-02-17

Applicant: Centro De Investigación En Alimentación Y Desarrollo, A.C. (CIAD) ,  Belinda Vallejo Galland ,  Aarón Fernando González Córdova

Inventor： Belinda Vallejo Galland ,  Aarón Fernando González Córdova ,  Jóse Carlos Rodriguez Figueroa

IPC: A61K35/20 ,  A61K38/08 ,  A61K35/744 ,  C12P21/00 ,  C12P21/06 ,  C12R1/00 ,  A23C9/123 ,  A61K35/74 ,  A23C9/152 ,  A23L2/52 ,  A61K35/742 ,  A61K38/10 ,  C12N1/20 ,  A23L33/135 ,  A23L2/38 ,  A61K9/00 ,  C12R1/01 ,  A61K35/00

CPC classification number: A61K38/08 ,  A23C9/123 ,  A23C9/1234 ,  A23C9/152 ,  A23C9/1526 ,  A23L2/382 ,  A23L2/52 ,  A23L33/135 ,  A23V2002/00 ,  A23Y2240/41 ,  A61K9/0053 ,  A61K9/0095 ,  A61K35/74 ,  A61K35/742 ,  A61K35/744 ,  A61K38/10 ,  A61K2035/115 ,  C12N1/20 ,  C12P21/00 ,  C12P21/06 ,  C12R1/00 ,  C12R1/01

Abstract: New Lactococcus lactis strains, NRRL B-50571 and NRRL B-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower LDL-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation.

公开(公告)号：US20170065666A1

公开(公告)日：2017-03-09

申请号：US15357170

申请日：2016-11-21

Applicant: Belinda Vallejo Galland ,  Aarón Fernando González Córdova ,  Centro De Investigación En Alimentación Y Desarrollo, A.C. (CIAD)

Inventor： Belinda Vallejo Galland ,  Aarón Fernando González Córdova ,  Jóse Carlos Rodríguez Figueroa

IPC: A61K38/08 ,  A23L2/38 ,  A61K35/744 ,  A23C9/123 ,  A23L2/52 ,  A61K38/10 ,  A23C9/152

CPC classification number: A61K38/08 ,  A23C9/123 ,  A23C9/1234 ,  A23C9/152 ,  A23C9/1526 ,  A23L2/382 ,  A23L2/52 ,  A23L33/135 ,  A23V2002/00 ,  A23Y2240/41 ,  A61K9/0053 ,  A61K9/0095 ,  A61K35/74 ,  A61K35/742 ,  A61K35/744 ,  A61K38/10 ,  A61K2035/115 ,  C12N1/20 ,  C12P21/00 ,  C12P21/06 ,  C12R1/00 ,  C12R1/01

Abstract: New Lactococcus lactis strains, NRRL B-50571 and NRRL B-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower LDL-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation.

Abstract translation: 新的乳酸乳球菌菌株，NRRL B-50571和NRRL B-50572以及含有该乳酸菌的细菌制剂具有生产降低血压，降低LDL-胆固醇（坏胆固醇）和呈现抗氧化性能以获得更好心血管的生物活性肽的能力 健康。 这些生物活性肽可以在食品中生产用于生产食品，例如功能性食品，或者它们可以由蛋白质来源生产，随后作为制剂的一部分添加到食物中或作为食品补充剂的一部分 或药物制剂。

公开(公告)号：US20170007629A1

公开(公告)日：2017-01-12

申请号：US14796372

申请日：2015-07-10

Applicant: Mead Johnson Nutrition Company

Inventor： Chenzhong Kuang ,  Dirk Hondmann ,  Robert J. McMahon ,  Yan Xiao

IPC: A61K31/685 ,  A23C9/152 ,  A61K31/688 ,  A61K31/202 ,  A61K38/40 ,  A61K35/747

CPC classification number: A61K31/685 ,  A23C9/152 ,  A23C9/1528 ,  A23L33/00 ,  A23L33/10 ,  A23L33/12 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/322 ,  A23V2250/1848 ,  A23V2250/1862 ,  A23V2250/1868 ,  A23V2250/54248 ,  A61K31/202 ,  A61K31/688 ,  A61K35/747 ,  A61K38/40

Abstract: The present disclosure provides a composition and method for promoting functional neuronal development in pediatric subjects. The composition comprises in some embodiments up to about 7 g/100 Kcal of a fat or lipid source; up to about 5 g/100 Kcal of a protein source; about 3 mg/100 Kcal to about 50 mg/100 Kcal of phosphatidylethanolamine; about 0.15 mg/100 Kcal to about 75 mg/100 Kcal of sphingomyelin; and about 5 mg/100 Kcal to about 75 mg/100 Kcal of docosahexaenoic acid. The methods comprise, in some embodiments, administering the aforementioned composition to a pediatric subject.

Abstract translation: 本公开提供了用于促进儿科受试者功能性神经元发育的组合物和方法。 组合物在一些实施方案中包含高达约7g / 100Kcal的脂肪或脂质来源; 高达约5g / 100Kcal的蛋白质来源; 约3mg / 100Kcal至约50mg / 100kcal磷脂酰乙醇胺; 约0.15mg / 100Kcal至约75mg / 100Kcal鞘磷脂; 和约5mg / 100Kcal至约75mg / 100Kcal二十二碳六烯酸。 在一些实施方案中，所述方法包括将前述组合物施用于儿科受试者。

公开(公告)号：US20160303226A1

公开(公告)日：2016-10-20

申请号：US15038666

申请日：2014-11-04

Applicant: NESTEC S.A.

Inventor： Annick Mercenier ,  Guenolee Prioult

IPC: A61K39/35 ,  A23C9/123 ,  A23C9/152 ,  A61K9/00

CPC classification number: A61K39/35 ,  A23C9/123 ,  A23C9/152 ,  A23K10/16 ,  A23K50/40 ,  A23L33/135 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/00 ,  A23Y2300/49 ,  A61K9/0053 ,  A61K9/0095 ,  A61K35/745 ,  A61K2039/522 ,  A61K2039/542 ,  A61K2039/577 ,  A61K2039/58 ,  A23V2200/304 ,  A23V2200/3202 ,  A23V2200/3204

Abstract: Heat treated Bifidobacterium lactis NCC 2818 reduces the symptoms of allergies in different groups of patients, such as allergies originating from food allergens in young children, or infants, and food, respiratory and cutaneous allergens in children, adults and household pets. The heat treated Bifidobacterium lactis NCC 2818 may be administered alone or in a composition. A reduction of allergy symptoms has been measured, in vivo, in a mouse allergy model.

Abstract translation: 热处理的双乳双歧杆菌NCC 2818减少了不同组患者的过敏症状，例如儿童，成人和家庭宠物中幼儿或儿童食物过敏原的过敏症，食物，呼吸道和皮肤过敏原。 热处理的乳酸双歧杆菌NCC2818可以单独施用或组合施用。 在体内，在小鼠过敏模型中已经测量出过敏症状的减少。

公开(公告)号：US20160135482A1

公开(公告)日：2016-05-19

申请号：US15006312

申请日：2016-01-26

Applicant: BURCON NUTRASCIENCE (MB) CORP.

Inventor： Kevin I. Segall ,  Martin Schweizer

IPC: A23J1/14 ,  A23J3/14

CPC classification number: A23J1/14 ,  A21D2/266 ,  A21D13/064 ,  A23C9/152 ,  A23C11/06 ,  A23J1/142 ,  A23J3/14 ,  A23L2/66 ,  A23L13/426 ,  A23L33/185 ,  A23V2002/00 ,  A23V2200/06 ,  A23V2250/548 ,  A23V2300/14 ,  A23V2300/34

Abstract: An aqueous solution of a pulse protein product having a protein content of at least about 60 wt % (N×6.25) d.b. which is soluble in aqueous media at a pH of less than about 4.4 and heat stable at that pH range is adjusted in pH to a pH of about 6 to about 8. The resulting product is further processed by drying the product, recovering and drying any precipitated pulse protein material, heat treating and then drying the product, or heat treating the product and recovering and drying any precipitated pulse protein material.